Canto-de Cetina TE, Polanco-Reyes LE, Fernández-González V, Cupul DG

Language: Spanish
References: 29
Page: 25-30
PDF size: 59.14 Kb.

ABSTRACT

Objective: To determine the prevalence of bacterial vaginosis among family planning users and the relationship between clinical symptoms and gynecologic signs. Material and methods: Four hundred and fifty women were studied: they answered a detailed structured questionnaire and had a vaginal secretion sampling to make the diagnose of bacterial vaginosis according to the Amsel et al criteria. Results: 85 women were excluded because they were found to lave either yeast or trichomonas .144/450 women were found to have bacterial vaginosis (32%), while 221 women without evidence of this problem served as a comparison group. We found an increased number of sexual partners, and more abortions and premature rupture of membranes in women with bacterial vaginosis than women without the problem. More than 50 % of patients with bacterial vaginosis were asymptomatic of disease complaints and the only sign with significance observed in bacterial vaginosis patients was a grey vaginal discharge. Use of IUD wasn’t associated with bacterial vaginosis. Conclusions: The prevalence of bacterial vaginosis we found in a family planning clinic was similar to those that have been reported in developed countries whereas it seems to be higher than other national studies .We must emphasize the importance of an accurate diagnose and a suitable treatment to prevent subsequent complications.

REFERENCES

1. Spiegel CA, Amsel R, Eschenbach DJ, Schoenknecht F, Holmes KK. Anaerobic bacteria in non-specific vaginitis. N Engl J Med 1980;303:601-7.

2. Redondo-López V, Cook RL, Sohel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 1990;12:856-72.

3. Hill GB. The microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993;169:450-4.

4. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Am J Med 1983;74:14-22.

5. Berg AO, Heidrich FE, Fihn SD et al. Establishing the cause of genitourinary symptoms in women in a family practice. JAMA 1984;251:620-25.

6. Gravett MG, Nelson HP, DeRouen T, Critchlow CW, Eschenbach DA, Holmes KK. Independent association of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899-903.

7. Schenbach DA, Hillier SL, Critchlow CW, et al. Diagnosis and clinical features associated with bacterial vaginosis. Am J. Obstet Gynecol 1988;158:819-28.

8. Marthius J, Krohn MA, Hillier SL, Stamm WE, Holmes KK, Eschenbach DA. Relationship of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 1988;71:89-95.

9. Larson PG, Platz-Christensen JJ, Thejls H, Forsum U, Pahison C. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind randomized study. Am J Obstet Gynecol 1992;166:l00-103.

10. Peipert JF, Boyd Montagno A, Sedlacek Cooper A, Sung CJ. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet and Gynecol 1997;177:1184-7.

11. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNairn D, Wabwire-Mangen F et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350:546-50.

12. Mayaud Ph. Tackling bacterial vaginosis and HIV in developing countries. Commentary. The Lancet 1997;350:530-31.

13. Driscoll SG. Significance of acute chorioamnionitis. Clin Obstet Gynecol 1979;22:339-49.

14. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of choriamnionitis in prematurity. N Engl J Med 1988;319;972-78.

15. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet gynecol 1992;166:1515-28.

16. Ralph SG, Rutherford AJ, Wilson JD. Influence of bacterial vaginosis on concepción and miscarriage in the first trimester: Cohort study. British Medical Journal 1999;319:220-23.

17. Mead PB. Epidemiology of bacterial vaginosis. Am J Obstet Gynecol 1993;169:446-49.

18. Gardner HL, Dampeer TK, Dukes CD. The prevalence of vaginitis. Am J Obstet Gynecol 1957;73:1080-87.

19. Lewis JF, O’Brien SM. Incidence of Haemophilus vaginalis. Am J Obstet gynecol 1969;103:843-46.

20. Gravett MG, Nelson HP, De Rouen T, et al. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;225:1899-903.

21. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Am J Med 1983;74:14-22.

22. Barbone F, Austin H, Louv WC, Alexander WJ. A follow-up study of methods of conception, sexual activity, and rates of trichomonasis, candidiasis, and bacterial vaginosis. Am J Obstet gynecol 1990;163:510-14.

23. Sahin HNN, ASlan D, Bertan M. Intrauterine device use and some issues related to sexually transmited disease screening and occurrence. Contraception 200;61:359-64.

24. Calzolari E, Masciangelo R, Milite V, Verteramo R. Bacterial vaginosis and contraceptive methods. Int J Gynecol Obstet 200;70:341-46.

25. Schmid GP. The epidemiology of bacterial vaginosis Int. J Gynecol Obstet. 1999;67:S17-S23.

26. Bacterial vaginosis screening for prevention of preterm delivery. ACOG committee opinion. Committee on obstetric practice. International Journal of Ginecology and Obstetrics 1998;61:311-312.

27. Nuriye NSH, Dilek A, Munevver B. Intrauterine device use and some issues related to sexually transmitted disease screening and ocurrence. Contraception 200;61:359-64.

28. Shoubnikova M, Hellberg D, Nilson S, Mardh P. Contraceptive use in women with bacterial vaginosis. Contraception 1997;55:355-58.

29. Rivera-Rivera L,Quiteiro-Trenado M,Cruz-Valdez A,Conde-González CJ. Prevalencia de vaginitis y vaginosis bacteriana: asociación con manifestaciones clinicas, de laboratorio y tratamiento. Ginecología Y Obstetricia de México 1996;64:26-35.